Old Web
English
Sign In
Acemap
>
authorDetail
>
Darko Miljkovic
Darko Miljkovic
Novartis
Medicine
Adverse effect
Clinical Practice
Clinical trial
Myeloid leukemia
2
Papers
18
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
TARGET: a survey of real-world management of chronic myeloid leukaemia across 33 countries.
2020
British Journal of Haematology
Anna G. Turkina
Jianxiang Wang
Vikram Mathews
Guray Saydam
Chul-Won Jung
Hani Al-Hashmi
Mohamed A. Yassin
Solenn Le Clanche
Darko Miljkovic
Cassandra Slader
Timothy P. Hughes
Show All
Source
Cite
Save
Citations (15)
Safety and efficacy of nilotinib in routine clinical practice in patients with chronic myeloid leukemia in chronic or accelerated phase with resistance or intolerance to imatinib: results from the NOVEL study:
2018
Therapeutic advances in hematology
Ching Yuan Kuo
Po-Nan Wang
Wen-Li Hwang
Cheng-Hwai Tzeng
Li-Yaun Bai
Jih-Luh Tang
Ming Chih Chang
Sheng-Fung Lin
Tsai-Yun Chen
Yeu Chin Chen
Tran-Der Tan
Chih-Yi Hsieh
Chinjune Lin
Clinton Lai
Darko Miljkovic
Cheng-Shyong Chang
Show All
Source
Cite
Save
Citations (3)
1